Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
Efficacy of Nordic Walking in Improving Walking Ability in Patients on Peritoneal Dialysis: A Randomized Controlled Trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sonoda Rena Sumura, Uchiyama Kiyotaka, Inaba Yuka, Kasahara Chiaki, Sato Tomoki, Kaihara Ayaka, Yamada Shohei, Urate Shingo, Yanagi Mai, Kinugasa Satoshi, Tanaka Kiyokazu, Kunoki Junichi, Ishibashi Yoshitaka
Аннотация
BACKGROUND: Nordic walking (NW) is a four-point walking style that may improve exercise tolerance in chronic diseases, but its effects in peritoneal dialysis (PD) patients remain unclear.
METHODS: PD patients with sarcopenia and/or musculoskeletal pain were randomly assigned to NW or usual care. The intervention consisted of NW for 20-30 min/day, at least three times per week for 12 weeks. The primary endpoint was the change in 6-min walking distance (6MWD).
RESULTS: Twenty-four patients were enrolled (13 in the intervention group, 11 in the usual care group; age 74.0 ± 6.8 years; 6MWD 391.0 ± 58.1 m). Instructional compliance was 96% in the intervention group. The change in 6MWD was greater in the intervention group than in usual care (33.1 ± 33.5 vs. 4.9 ± 32.9 m), reaching borderline significance (p = 0.05).
CONCLUSION: NW may be associated with improved walking ability in PD patients with sarcopenia or musculoskeletal pain, with a high adherence rate.
TRIAL REGISTRATION: UMIN-CTR no.: UMIN 000052466.
METHODS: PD patients with sarcopenia and/or musculoskeletal pain were randomly assigned to NW or usual care. The intervention consisted of NW for 20-30 min/day, at least three times per week for 12 weeks. The primary endpoint was the change in 6-min walking distance (6MWD).
RESULTS: Twenty-four patients were enrolled (13 in the intervention group, 11 in the usual care group; age 74.0 ± 6.8 years; 6MWD 391.0 ± 58.1 m). Instructional compliance was 96% in the intervention group. The change in 6MWD was greater in the intervention group than in usual care (33.1 ± 33.5 vs. 4.9 ± 32.9 m), reaching borderline significance (p = 0.05).
CONCLUSION: NW may be associated with improved walking ability in PD patients with sarcopenia or musculoskeletal pain, with a high adherence rate.
TRIAL REGISTRATION: UMIN-CTR no.: UMIN 000052466.